ANHYDROUS DOCETAXEL, FLUOROURACIL, FLUOROURACIL, OXALIPLATIN, CALCIUM LEVOFOLINATE
PRODIGE 51 - GASTFOX
Phase 3 small_molecule active
Quick answer
ANHYDROUS DOCETAXEL, FLUOROURACIL, FLUOROURACIL, OXALIPLATIN, CALCIUM LEVOFOLINATE for Locally advanced or metastatic oesogastric adenocarcinoma is a Phase 3 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- Locally advanced or metastatic oesogastric adenocarcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active